Growth stocks have been hit the hardest in the ongoing bear market. The Nasdaq Composite index is a good gauge of the growth sector since it is heavy with technology companies. There is more risk with owning Tesla (NASDAQ: TSLA) than many other growth stocks because of how expensive the stock became relative to its business metrics. Read More...
Motley Fool
Why Shares of Vertex Pharmaceuticals Jumped 9.03% on Friday
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX), a biopharmaceutical stock that specializes in cystic fibrosis (CF) and gene-editing therapies, saw its shares jump 9.03% on Friday. The company released its third-quarter earnings report after the market closed on Thursday and the numbers were strong enough to give the stock a boost on Friday. Vertex reported revenue of $2.33 billion, up 18% year over year, and net income of $931 million and earnings per share (EPS) of $3.59, both up 9% over the same period in 2021.
Add Comment